# A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV

> **NCT07445893** · NA · NOT_YET_RECRUITING · sponsor: **Duan Minghui** · enrollment: 30 (estimated)

## Conditions studied

- Polycythemia Vera (PV)

## Interventions

- **DRUG:** Gecacitinib Hydrochloride Tablets；Pegylated interferon alfa-2b

## Key facts

- **NCT ID:** NCT07445893
- **Lead sponsor:** Duan Minghui
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-24
- **Primary completion:** 2026-12-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07445893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07445893, "A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07445893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*